HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Minority Interest (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Minority Interest came in at $14.2 million in Q2 2026, up 10.37% year-over-year from $12.9 million in Q2 2025, and up 6.42% quarter-over-quarter from $13.3 million in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Minority Interest (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Minority Interest for 12 consecutive years, with $14.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Minority Interest rose 10.37% year-over-year to $14.2 million in Q2 2026; TTM through Jun 2026 was $14.2 million, a 10.37% increase from a year earlier, with the FY2025 full-year figure at $13.3 million, changed N/A from the prior year.
  • Minority Interest was $14.2 million for Q2 2026 at HUTCHMED (China), up from $13.3 million in the prior quarter.
  • Over five years, Minority Interest peaked at $52.1 million in Q2 2022 and troughed at $11.9 million in Q2 2024.
  • A 5-year average of $21.3 million and a median of $14.2 million in 2026 frame the typical range for Minority Interest.
  • Across the five-year window, Minority Interest jumped 80.35% in 2022 and slumped 65.51% in 2023, its largest moves.
  • Over 5 years, Minority Interest stood at $26.5 million in 2022, then slumped by 32.17% to $18.0 million in 2023, then sank by 33.62% to $11.9 million in 2024, then gained by 11.75% to $13.3 million in 2025, then advanced by 6.42% to $14.2 million in 2026.
  • The last three Minority Interest figures came in at $14.2 million (Q2 2026), $13.3 million (Q4 2025), and $12.9 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.51 Bn 197.52 Bn 7.24 Bn
2 Gilead Sciences 181.48 Bn 178.30 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.45 Bn 124.60 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.87 Bn 74.88 Bn 3.93 Bn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn
6 Moderna 54.72 Bn 49.59 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn
9 Roivant Sciences 30.31 Bn 30.31 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.19 Mn
Dec 31, 2025 13.34 Mn
Jun 30, 2025 12.86 Mn
Jun 30, 2024 11.93 Mn
Jun 30, 2023 17.98 Mn
Dec 31, 2022 26.50 Mn
Jun 30, 2022 52.12 Mn
Dec 31, 2021 52.62 Mn
Jun 30, 2021 28.90 Mn
Mar 31, 2021 36.12 Mn
Dec 31, 2020 34.83 Mn
Jun 30, 2020 24.93 Mn
Dec 31, 2019 24.89 Mn
Sep 30, 2019 24.27 Mn
Jun 30, 2019 25.15 Mn
Mar 31, 2019 24.59 Mn
Dec 31, 2018 23.26 Mn
Jun 30, 2018 26.11 Mn
Dec 31, 2017 23.23 Mn
Jun 30, 2017 22.12 Mn